Human Papillomavirus-Related Carcinoma — Trials

Human Papillomavirus-Related Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

154 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 67
Recruiting: 36
Ph III recruiting: 2
Growth YoY: —
Industry share: 22%
Top sponsor: National Cancer Institute (NCI)
Termination share: 27.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (13)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04255849	Nine-valent HPV Vaccine to Prevent Persistent Oral HPV Infection in Men Living With HIV	active not recruiting	Phase 3	700	Weill Medical College of Cornell UniversityOTHER	3	Sep 14, 2026	clinicaltrials
NCT06465914	A Phase III Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent HPV Vaccine in Chinese Males	active not recruiting	Phase 3	9,000	Shanghai Bovax Biotechnology Co., Ltd.INDUSTRY	1	Dec 12, 2024